Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation

Yifan Li; Diwen Zhu; Weixin Ren; Junpeng Gu; Weizheng Ji; Haixiao Zhang; Yingjun Bao; Gengfei Cao; Asihaer Hasimu

doi:10.12659/MSM.936246

21 May 2022 : Clinical Research

Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation

Yifan Li^1AE, Diwen Zhu^1BCD, Weixin Ren^1AE*, Junpeng Gu^1BCD, Weizheng Ji^1BCD, Haixiao Zhang^1BCD, Yingjun Bao^1BCD, Gengfei Cao^1BCD, Asihaer Hasimu^1BCD

DOI: 10.12659/MSM.936246

Med Sci Monit 2022; 28:e936246

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Association of the high-risk group with progression or death in 1 year compared with the low-risk group.

	Model 1		Model 2		Model 3
	HR	P	HR	P	HR	P
High-risk group compared to low-risk group	6.70 (3.647–12.309)	<0.001	6.651 (3.620–12.221)	<0.001	12.232 (6.005–24.916)	<0.001
HR – hazard risk; CI – confidence interval. did not adjust for confounders; adjusted the number of TACE during the first treatment and LDH; adjusted the number of TACE during the first treatment, LDH, tumor location, tumor size, PVTT, hepatitis, CP, BCLC, and CNLC.

Back to the Article

Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation

Your Privacy